Response to: High Flow Oxygen Therapy in ILD Exacerbation—An Imperfect Therapy

L White; Meena Kalluri

doi:10.1093/annalsats/aaoag154

June 13, 2026Annals of the American Thoracic Society

Response to: High Flow Oxygen Therapy in ILD Exacerbation—An Imperfect Therapy

View at Publisher

Ask AI

Bookmark

Share

Key Points

This response evaluates the effectiveness and limitations of high flow oxygen therapy in interstitial lung disease exacerbations.
The authors critically review existing literature on high flow oxygen therapy for interstitial lung disease.
Analysis focuses on clinical outcomes associated with therapy during exacerbation events.
High flow oxygen therapy has mixed outcomes in interstitial lung disease exacerbations.
Some patients experience limited benefits, highlighting therapy's imperfections.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Response addresses high flow oxygen therapy effectiveness during exacerbations of interstitial lung disease, suggesting limitations.

Abstract

Laura White, Meena Kalluri; Response to: High Flow Oxygen Therapy in ILD Exacerbation—An Imperfect Therapy, Annals of the American Thoracic Society, , aaoa

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

White et al. (2026) studied this question.

synapsesocial.com/papers/6a323cc9d50b63ecad206c92 https://doi.org/10.1093/annalsats/aaoag154

View at Publisher

Ask AI

Bookmark

Share

Response to: High Flow Oxygen Therapy in ILD Exacerbation—An Imperfect Therapy

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Response to: High Flow Oxygen Therapy in ILD Exacerbation—An Imperfect Therapy

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading